Sana Biotechnology (SANA) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 4, 2026, will be held virtually via live audio webcast.

• Proxy materials are available online, with paper copies available upon request by May 25, 2026.

• Voting is accessible online using a 12-digit control number provided to shareholders.

Voting matters and shareholder proposals

• Shareholders will vote to elect three Class II directors for three-year terms expiring at the 2029 annual meeting.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Proxies may vote on any other business that may properly come before the meeting.

Board of directors and corporate governance

• Nominees for election to the board are Hans E. Bishop, Robert Nelsen, and Alise S. Reicin, M.D.

• Board recommends voting FOR each director nominee and FOR the auditor ratification proposal.